A detailed history of Highlander Capital Management, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Highlander Capital Management, LLC holds 250 shares of BHC stock, worth $1,777. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 500 50.0%
Holding current value
$1,777
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

SELL
$7.77 - $10.61 $1,942 - $2,652
-250 Reduced 50.0%
250 $2,000
Q4 2023

Jan 24, 2024

BUY
$6.53 - $8.23 $3,265 - $4,115
500 New
500 $4,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.57B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Highlander Capital Management, LLC Portfolio

Follow Highlander Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highlander Capital Management, LLC with notifications on news.